Your web browser is out of date.
For your security and improved experience online, please update your browser.
Your web browser is out of date.
Diabetes on the Net is intended for healthcare professionals
on-demand video
Learning objectives:
This promotional video presentation was originally broadcast on 16 September 2021. Please note that the speakers are not able to answer questions from attendees watching the video on-demand.
Click here for Trulicity® (dulaglutide) Prescribing Information and Adverse Event Reporting
Trulicity is indicated for the treatment of adults with insufficiently controlled type 2 diabetes mellitus as an adjunct to diet and exercise
• as monotherapy when metformin is considered inappropriate due to intolerance or contraindications.
• in addition to other medicinal products for the treatment of diabetes mellitus
Company profile
Lilly has been a global leader in diabetes care since 1923. Today, we are building upon this heritage by working to meet the diverse needs of people living with diabetes and those who care for them. Through research and collaboration, a wide range of therapies, and a continued determination to provide real solutions – from medicines to support programmes and more – we strive to make life better for all those affected by diabetes around the world.
This content is for UK & ROI Healthcare Professionals only. Lilly has provided sponsorship for the delivery of the conference and have only had input into the symposium sessions which they have sponsored.
This content is for UK & ROI Healthcare Professionals only. This resource page and the materials included have been organised and supported by Lilly.
PP-LD-IE-0061 | November 2021
get the latest news
subscribe now
© Copyright OmniaMed Communications. All Rights Reserved
We use cookies to ensure that we give you the best experience on our website. Some may have been set already. If you continue without changing your settings, we’ll assume that you are happy to receive all cookies on this website. Read about how we use cookies. If you have any concerns about this, please click here to find out more.